C-FOS inhibition promotes pancreatic cancer cell ferroptosis by transcriptionally regulating the expression of SLC7A11
Functional & Integrative Genomics · 2024
DOI: 10.1007/s10142-024-01429-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Functional & Integrative Genomics, 2024. Verfasst von Shuangjia Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Pancreatic Vascular Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, N…. Hauptthemen laut MEDLINE: Amino Acid Transport System y+, Ferroptosis, Gene Expression Regulation, Neoplastic, Pancreatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Cellular proto-oncogene C-Fos forms the AP-1 transcription factor by dimerizing with proto-oncogene c-Jun; this factor upregulates the transcription of genes associated with different malignancies. However, its functions in pancreatic adenocarcinoma (PAAD) remain poorly understood. In this study, the c-Fos was increased in PAAD cells and tissues through bioinformatic analysis, RT-PCR, and WB. In two PAAD cell lines, PANC-1 and BxPC-3, we performed c-Fos knockdown studies using short hairpin RNA (shRNA). Functional analysis indicated that c-Fos depletion in PAAD cells inhibits cell proliferation and promotes ferroptosis. Chromatin Immunoprecipitation (ChIP) and Dual-luciferase experiments showed that c-Fos coupled to the promoter region of SLC7A11 stimulated its transcription, providing mechanistic insight into the process. Moreover, SLC7A11 blocked the decline of proliferation and ferroptosis by c-Fos knockdown in PAAD cells. Furthermore, a xenograft nude mouse model was established to study the impact of c-Fos on tumorigenesis in vivo. Depletion of c-Fos could suppress PC tumor growth and the expressions of SLC7A11, ki-67, and 4HNE, but overexpression of SLC7A11 reversed this process. In summary, our investigation has shown that c-Fos acts as a transcriptional regulator of SLC7A11, which may enhance tumour growth in pancreatic cancer by inhibiting ferroptosis. These results indicate that c-Fos might be a promising target for treating ferroptosis in PAAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Pancreatic Vascular Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, No 55 Zhenhai Road, Xiamen, 361003, Fujian, China.
- Department of Hepatobiliary Pancreatic Vascular Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, No 55 Zhenhai Road, Xiamen, 361003, Fujian, China. wangshuangjia04913@1…
Zitieren
APA
Wang, S., Yu, H., Guo, P., Feng, L., & Li, Z. (2024). C-FOS inhibition promotes pancreatic cancer cell ferroptosis by transcriptionally regulating the expression of SLC7A11. Functional & Integrative Genomics. https://doi.org/10.1007/s10142-024-01429-5
Vancouver
Wang S, Yu H, Guo P, Feng L, Li Z. C-FOS inhibition promotes pancreatic cancer cell ferroptosis by transcriptionally regulating the expression of SLC7A11. Functional & Integrative Genomics. 2024. doi:10.1007/s10142-024-01429-5
BibTeX
@article{Wang2024,
author = {Wang, Shuangjia and Yu, Hao and Guo, Ping and Feng, Liuxing and Li, Zhimin},
title = {C-FOS inhibition promotes pancreatic cancer cell ferroptosis by transcriptionally regulating the expression of SLC7A11},
journal = {Functional & Integrative Genomics},
year = {2024},
doi = {10.1007/s10142-024-01429-5}
}
EUVIMED